These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1066 related articles for article (PubMed ID: 8072547)

  • 1. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK.
    Deng T; Karin M
    Nature; 1994 Sep; 371(6493):171-5. PubMed ID: 8072547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo.
    Fisher GJ; Talwar HS; Lin J; Lin P; McPhillips F; Wang Z; Li X; Wan Y; Kang S; Voorhees JJ
    J Clin Invest; 1998 Mar; 101(6):1432-40. PubMed ID: 9502786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstitution of signal transduction from the membrane to the nucleus in a baculovirus expression system: activation of Raf-1 leads to hypermodification of c-jun and c-fos via multiple pathways.
    Agarwal S; Corbley MJ; Roberts TM
    Oncogene; 1995 Aug; 11(3):427-38. PubMed ID: 7543194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.
    O'Hagan RC; Tozer RG; Symons M; McCormick F; Hassell JA
    Oncogene; 1996 Sep; 13(6):1323-33. PubMed ID: 8808707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
    Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
    Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling pathways in the induction of c-fos and c-jun proto-oncogenes by 3-methylcholanthrene.
    Ainbinder E; Bergelson S; Daniel V
    Recept Signal Transduct; 1997; 7(4):279-89. PubMed ID: 9633828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
    Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
    Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. v-Jun represses c-jun proto-oncogene expression in vivo through a 12-O-tetradecanoylphorbol-13-acetate-responsive element in the proximal gene promoter.
    Hussain S; Kilbey A; Gillespie DA
    Cell Growth Differ; 1998 Aug; 9(8):677-86. PubMed ID: 9716184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stress-activated protein kinase subfamily of c-Jun kinases.
    Kyriakis JM; Banerjee P; Nikolakaki E; Dai T; Rubie EA; Ahmad MF; Avruch J; Woodgett JR
    Nature; 1994 May; 369(6476):156-60. PubMed ID: 8177321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat.
    Ferrer I; Blanco R; Carmona M; Puig B; Domínguez I; Viñals F
    Acta Neuropathol; 2002 Apr; 103(4):391-407. PubMed ID: 11904760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism.
    Arai H; Escobedo JA
    Mol Pharmacol; 1996 Sep; 50(3):522-8. PubMed ID: 8794890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
    Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
    J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of anisomycin on activation of early response genes c-fos, c-jun, Egr-1 in cells transformed by E1A and cHa-ras oncogenes].
    Kukushkin AN; Svetlikova SB; Pospelov VA
    Mol Biol (Mosk); 2005; 39(1):80-8. PubMed ID: 15773551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Jun functions as a calcium-regulated transcriptional activator in the absence of JNK/SAPK1 activation.
    Cruzalegui FH; Hardingham GE; Bading H
    EMBO J; 1999 Mar; 18(5):1335-44. PubMed ID: 10064599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta 1 integrin- and proteoglycan-mediated stimulation of T lymphoma cell adhesion and mitogen-activated protein kinase signaling by thrombospondin-1 and thrombospondin-1 peptides.
    Wilson KE; Li Z; Kara M; Gardner KL; Roberts DD
    J Immunol; 1999 Oct; 163(7):3621-8. PubMed ID: 10490955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. elk-1 proteins interact with MAP kinases.
    Rao VN; Reddy ES
    Oncogene; 1994 Jul; 9(7):1855-60. PubMed ID: 8208531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of c-jun mediated by MAP kinases.
    Pulverer BJ; Kyriakis JM; Avruch J; Nikolakaki E; Woodgett JR
    Nature; 1991 Oct; 353(6345):670-4. PubMed ID: 1922387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain.
    Binétruy B; Smeal T; Karin M
    Nature; 1991 May; 351(6322):122-7. PubMed ID: 1903181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of serine/threonine protein kinases and early growth response 1 gene expression by tumor necrosis factor in human myeloid leukemia cells.
    Saleem A; Yuan ZM; Taneja N; Rubin E; Kufe DW; Kharbanda SM
    J Immunol; 1995 Apr; 154(8):4150-6. PubMed ID: 7706752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.